 - Any prior systemic therapy for HCC, including systemic chemotherapy prior exposure to chemotherapy by TACE is allowed, immunotherapy, sorafenib or other Raf kinase inhibitors, VEGFVEGFR-inhibitors, epidermal growth factor receptor inhibitors or mTOR inhibitors 